Search Results

There are 26946 results for: content related to: Adalimumab treatment in patients with rheumatoid arthritis with renal insufficiency

  1. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  2. You have free access to this content
    Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

    The Journal of Dermatology

    Volume 37, Issue 4, April 2010, Pages: 299–310, Akihiko ASAHINA, Hidemi NAKAGAWA, Takafumi ETOH, Mamitaro OHTSUKI and THE ADALIMUMAB M04-688 STUDY GROUP

    Article first published online : 26 FEB 2010, DOI: 10.1111/j.1346-8138.2009.00748.x

  3. The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 8, August 2012, Pages: 991–998, H.-Y. Chiu, T.-S. Wang, C.-Y. Chang and T.-F. Tsai

    Article first published online : 4 AUG 2011, DOI: 10.1111/j.1468-3083.2011.04199.x

  4. Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1044–1055, C. Ma, V. Huang, D. K. Fedorak, K. I. Kroeker, L. A. Dieleman, B. P. Halloran and R. N. Fedorak

    Article first published online : 3 SEP 2014, DOI: 10.1111/apt.12940

  5. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  6. You have free access to this content
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

    Arthritis & Rheumatism

    Volume 64, Issue 12, December 2012, Pages: 3850–3855, Charlotte L. Krieckaert, Anna Jamnitski, Michael T. Nurmohamed, Piet J. Kostense, Maarten Boers and Gertjan Wolbink

    Article first published online : 28 NOV 2012, DOI: 10.1002/art.34680

  7. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 658–667, C. Leonardi, J.M. Sobell, J.J. Crowley, U. Mrowietz, Y. Bao, P.M. Mulani, Y. Gu and M.M. Okun

    Article first published online : 20 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11041.x

  8. You have free access to this content
    Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1324–1332, F. Baert, N. Vande Casteele, S. Tops, M. Noman, G. Van Assche, P. Rutgeerts, A. Gils, S. Vermeire and M. Ferrante

    Article first published online : 2 OCT 2014, DOI: 10.1111/apt.12968

  9. You have free access to this content
    Caspase activation and apoptosis induction by adalimumab: Demonstration in vitro and in vivo in a chimeric mouse model

    Inflammatory Bowel Diseases

    Volume 12, Issue 1, January 2006, Pages: 22–28, Chong Shen, Gert Van Assche, Paul Rutgeerts and Jan L Ceuppens

    Article first published online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000194185.69800.07

  10. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 838–846, P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. De Jong

    Article first published online : 22 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09950.x

  11. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Article first published online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  12. You have free access to this content
    Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1912–1921, Jason M. Swoger, Edward V. Loftus Jr., William J. Tremaine, William A. Faubion, Darrell S. Pardi, Sunanda V. Kane, Karen A. Hanson, W. Scott Harmsen, Alan R. Zinsmeister and William J. Sandborn

    Article first published online : 1 APR 2010, DOI: 10.1002/ibd.21272

  13. You have full text access to this OnlineOpen article
    Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 10, November 2013, Pages: 1236–1247, R. Panaccione, J.-F. Colombel, W. J. Sandborn, G. D'Haens, Q. Zhou, P. F. Pollack, R. B. Thakkar and A. M. Robinson

    Article first published online : 22 SEP 2013, DOI: 10.1111/apt.12499

  14. You have free access to this content
    Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 818–825, David T. Rubin, Parvez Mulani, Jingdong Chao, Paul F. Pollack, Arielle G. Bensimon, Andrew P. Yu and Subrata Ghosh

    Article first published online : 1 SEP 2011, DOI: 10.1002/ibd.21836

  15. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Article first published online : 27 DEC 2012, DOI: 10.1002/art.37711

  16. You have free access to this content
    Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial

    Arthritis & Rheumatism

    Volume 56, Issue 2, February 2007, Pages: 476–488, Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin, Ernest H. S. Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok and Eric H. Sasso

    Article first published online : 30 JAN 2007, DOI: 10.1002/art.22379

  17. You have free access to this content
    Long-term durability of response to adalimumab in Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 685–690, M. Chaparro, J. Panés, V. García, O. Merino, P. Nos, E. Domènech, M. Peñalva, E. García-Planella, M. Esteve, J. Hinojosa, M. Andreu, F. Muñoz, A. Gutiérrez, J.L. Mendoza, J. Barrio, M. Barreiro-de, I. Vera, P. Vilar, J.L. Cabriada, M.A. Montoro, X. Aldeguer, C. Saro and J.P. Gisbert

    Article first published online : 25 MAY 2011, DOI: 10.1002/ibd.21758

  18. Adalimumab (Humira)

    Handbook of Therapeutic Antibodies

    Hartmut Kupper, Jochen Salfeld, Daniel Tracey, Joachim R. Kalden, Pages: 696–732, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch27

  19. Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

    Arthritis & Rheumatology

    Volume 66, Issue 9, September 2014, Pages: 2580–2589, Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Tony Hospach and Gerd Horneff

    Article first published online : 26 AUG 2014, DOI: 10.1002/art.38741

  20. Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 5, May 2013, Pages: 593–600, P.P.M. van Lümig, P.C.M. van de Kerkhof, J.B.M. Boezeman, R.J.B. Driessen and E.M.G.J. de Jong

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04496.x